España
India
Italia
대한민국
日本
My Account
Benzinga Edge
Benzinga Research
Benzinga Pro
Login
Get Benzinga Pro
Data & APIs
Events
Premarket
Advertise
Contribute
España
India
Italia
대한민국
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
Comments
Close menu
Loading...
Amgen
AMGN
NASDAQ
Watchlist
Leave a Comment
Logo brought to you by Benzinga Data
Get Report
Perks
Buy
Compare Brokers
Get Report
Perks
Buy
Compare Brokers
$303.01
5.08
1.71%
At close: -
$301.90
-1.11
-0.37%
After Hours: 6:29 PM EDT
Get Report
Comment
Amgen (AMGN) Forecast
News
Earnings
Amgen (AMGN) Options
Guidance
Dividends
Analyst Ratings
Insider Trades
Government Trades
Short Interest
Latest news for Amgen (NASDAQ:AMGN) Stock
Amgen Stock (NASDAQ: AMGN)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Friday, February 21, 2025
Derek Miller Takes Money Off The Table, Sells $593K In Amgen Stock
Benzinga Insights
FDA Says Novo Nordisk's Ozempic Injection .68...
Benzinga Newsdesk
Wednesday, February 19, 2025
Looking Into Amgen's Recent Short Interest
Benzinga Insights
Friday, February 14, 2025
EVP At Amgen Sells $2.59M Of Stock
Benzinga Insights
Wednesday, February 12, 2025
Amgen Unusual Options Activity For February 12
Benzinga Insights
Tuesday, February 11, 2025
10 Health Care Stocks With Whale Alerts In Today's Session
Benzinga Insights
Monday, February 10, 2025
Piper Sandler Maintains Overweight on Amgen, ...
Benzinga Newsdesk
Friday, February 07, 2025
Nancy A Grygiel Implements A Sell Strategy: Offloads $483K In Amgen Stock
Benzinga Insights
Thursday, February 06, 2025
Uber To $80? Here Are 10 Top Analyst Forecasts For Thursday
Avi Kapoor
B of A Securities Maintains Underperform on A...
Benzinga Newsdesk
Wednesday, February 05, 2025
Stocks Rebound, Google Eyes Worst Drop In A Year, Gold Shatters Fresh Records: What's Driving Markets Wednesday?
Piero Cingari
Amgen Impresses With Q4 Earnings Beat, Analysts See Growth Ahead
Vandana Singh
Amgen Options Trading: A Deep Dive into Market Sentiment
Benzinga Insights
Amgen shares are trading higher after the com...
Benzinga Newsdesk
Tuesday, February 04, 2025
Amgen Earnings Report: Q4 Overview
Benzinga Insights
Earnings Summary: Amgen Q4
Benzinga Insights
Amgen shares are trading lower. The company r...
Benzinga Newsdesk
Amgen Sees FY25 Revenue $34.3B-$35.7B Vs $34....
Benzinga Newsdesk
Amgen Q4 2024 Adj EPS $5.31 Beats $5.08 Estim...
Benzinga Newsdesk
US Stocks Rise Despite China's Trade Fears, Palantir Defies Gravity, Gold Rallies Further: What's Driving Markets Tuesday?
Piero Cingari
Earnings Scheduled For February 4, 2025
Benzinga Insights
Tuesday, January 28, 2025
Analyst Expectations For Amgen's Future
Benzinga Insights
Citigroup Maintains Neutral on Amgen, Lowers ...
Benzinga Newsdesk
Monday, January 27, 2025
This Is What Whales Are Betting On Amgen
Benzinga Insights
Friday, January 24, 2025
RBC Capital Reiterates Outperform on Amgen, M...
Benzinga Newsdesk
Wednesday, January 22, 2025
Cytokinetics Heart Drug's Future Sparks Optimism Despite M&A Hurdles and Royalty Deal Concerns: Analyst
Vandana Singh
Friday, January 17, 2025
Popular Ozempic, Wegovy Selected For Next Round Of Medicare Drug Price Negotiations
Vandana Singh
FDA Approves Amgen Treatment For Pretreated Colorectal Cancer With Certain Mutation
Vandana Singh
'Ozempic Is In The Next Round Of Medicare Dru...
Benzinga Newsdesk
Amgen Announced FDA Approval Of LUMAKRAS Comb...
Benzinga Newsdesk
Monday, January 13, 2025
Unpacking the Latest Options Trading Trends in Amgen
Benzinga Insights
Peering Into Amgen's Recent Short Interest
Benzinga Insights
Friday, January 10, 2025
Wells Fargo Maintains Equal-Weight on Amgen, ...
Benzinga Newsdesk
Thursday, January 09, 2025
Obesity Treatments, M&A Activity To Take Center Stage During Upcoming JPM Healthcare Conference
Vandana Singh
Wednesday, January 08, 2025
Asher Bio Announces Clinical Trial Collaborat...
Benzinga Newsdesk
Truist Securities Maintains Hold on Amgen, Lo...
Benzinga Newsdesk
Monday, January 06, 2025
UK Greenlights Amgen's Drug For Aggressive Lung Cancer In Pretreated Patients
Vandana Singh
Amgen's IMDYLLTRA Approved in UK for Advanced...
Benzinga Newsdesk
Friday, January 03, 2025
Wall Street's Most Accurate Analysts Spotlight On 3 Health Care Stocks Delivering High-Dividend Yields
Avi Kapoor
Thursday, January 02, 2025
Analyst Expectations For Amgen's Future
Benzinga Insights
Piper Sandler Maintains Overweight on Amgen, ...
Benzinga Newsdesk
Tuesday, December 31, 2024
Dogs Of The Dow: Top 10 High-Yield Stocks Offering Dividends Up To 6.8% In 2025
Chris Katje
Friday, December 27, 2024
Looking At Amgen's Recent Unusual Options Activity
Benzinga Insights
Thursday, December 26, 2024
10 Health Care Stocks With Whale Alerts In Today's Session
Benzinga Insights
Monday, December 23, 2024
Schwab US Dividend Equity ETF Reverses In December: What's Going On?
Erica Kollmann
Spotlight on Amgen: Analyzing the Surge in Options Activity
Benzinga Insights
Friday, December 20, 2024
What's Going On With Amgen Stock On Friday?
Vandana Singh
CORRECTION: Amgen shares are trading higher. ...
Benzinga Newsdesk
Friday, December 13, 2024
Drug Price Hikes Unsupported By Evidence Cost US $815 Million: ICER Report
Vandana Singh
"Weight-Loss Drug Craze Appears To Be Curbing...
Benzinga Newsdesk
Show More
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch